Skip to main content
OpenTrials

Clinical trial condition

Ductal Breast Carcinoma In Situ

Explore clinical trials studying Ductal Breast Carcinoma In Situ. Study availability and eligibility vary by location and protocol.

35 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Ductal Breast Carcinoma In Situ trial results

Completed

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

NCT01293032

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +18 more
Locations
  • Washington Cancer Institute Washington D.C., District of Columbia, United States
  • Carolinas Medical Center Charlotte, North Carolina, United States
  • Forsyth Regional Cancer Center Charlotte, North Carolina, United States
  • Cone Health Cancer Center Greensboro, North Carolina, United States
View Trial Details
Active, Not Recruiting

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

NCT01905046

Conditions
Adenocarcinoma, Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View all 27 locations
View Trial Details

Related conditions